{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:27:10Z","timestamp":1793165230252,"version":"4.5.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Mucormycosis is a rare disease characterized by its highly vascular invasiveness, rapid progression, and high mortality rate. Historically, reports on mucormycosis have been concentrated in the adult population, with few cases documented in pediatrics. Notably, there have been no reports of mucormycosis in either adults or children during the prevalence of mycoplasma pneumoniae.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>This paper presents two cases of newly diagnosed diabetic children who developed concurrent mucormycosis during mycoplasma pneumoniae infection. Both patients received aggressive antifungal therapy, with one surviving and the other succumbing to the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The paper discusses the diagnostic and therapeutic challenges of mucormycosis in patients with diabetes and concurrent mycoplasma pneumoniae, emphasizing the need for more proactive identification of infecting pathogens in the diabetic population during mycoplasma pneumoniae outbreaks. When routine anti-mycoplasma treatments are ineffective and chest enhanced CT scans reveal pulmonary vascular destruction, the possibility of mucormycosis should be considered. Particularly in patients with a history of corticosteroid use, clinical suspicion should be heightened. Concurrent mucormycosis infection may worsen patient outcomes, and further clinical exploration of the pathogenesis and treatment recommendations for mucormycosis associated with mycoplasma pneumoniae is warranted.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1516117","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T05:39:25Z","timestamp":1747028365000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Co-infection of mucormycosis with mycoplasma pneumoniae in children with diabetes mellitus: report of two rare cases"],"prefix":"10.3389","volume":"13","author":[{"given":"Yipaguli","family":"Simijiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawudan","family":"Abudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abulikemu","family":"Abudujielili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3201\/eid3007.240315","article-title":"Large-scale outbreak of mycoplasma pneumoniae infection, Marseille, France, 2023\u20132024","volume":"30","author":"Edouard","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2300724","DOI":"10.2807\/1560-7917.ES.2024.29.4.2300724","article-title":"Increased incidence of mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023","volume":"29","author":"Bolluyt","year":"2024","journal-title":"Euro Surveill"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2300707","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300707","article-title":"Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023","volume":"29","author":"Nordholm","year":"2024","journal-title":"Euro Surveill"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s00431-024-05519-1","article-title":"Challenges in the treatment of pediatric mycoplasma pneumoniae pneumonia","volume":"183","author":"Ding","year":"2024","journal-title":"Eur J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.diabet.2012.01.002","article-title":"Diabetes and mucormycosis: a complex interplay","volume":"38","author":"Rammaert","year":"2012","journal-title":"Diabetes Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0123021","DOI":"10.1128\/JCM.01230-21","article-title":"Epidemiology and antifungal susceptibilities of mucoralean fungi in clinical samples from the United States","volume":"59","author":"Badali","year":"2021","journal-title":"J Clin Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0009421","DOI":"10.1128\/CMR.00094-21","article-title":"Pathogenesis of respiratory viral and fungal coinfections","volume":"35","author":"Salazar","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/myc.13353","article-title":"Mucormycosis and COVID-19: an epidemic within a pandemic in India","volume":"64","author":"Selarka","year":"2021","journal-title":"Mycoses"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-023-03732-w","article-title":"What\u2019s behind China\u2019s mysterious wave of childhood pneumonia?","author":"Conroy","year":"2023","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","article-title":"Current status of mycoplasma pneumoniae infection in China","volume":"20","author":"Yan","year":"2024","journal-title":"World J Pediatr"},{"key":"B13","first-page":"73","article-title":"Guidelines for the diagnosis and treatment of mycoplasma pneumoniae pneumonia in children (2023 edition)","volume":"9","author":"Zhao","year":"2024","journal-title":"Emerg Infect Dis Electron Mag"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1089196","DOI":"10.3389\/fcimb.2023.1089196","article-title":"Mucor indicus caused disseminated infection diagnosed by metagenomic next-generation sequencing in an acute myeloid leukemia patient: a case report","volume":"13","author":"Shen","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/INF.0b013e318062115c","article-title":"Zygomycosis in children: a systematic review and analysis of reported cases","volume":"26","author":"Zaoutis","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"B16","first-page":"597","article-title":"[Expert consensus on diagnosis and management of mucormycosis in China]","volume":"62","year":"2023","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM\/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low-and middle- income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s15010-020-01561-x","article-title":"A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis","volume":"49","author":"Pasero","year":"2021","journal-title":"Infection"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/jcpt.13643","article-title":"Treatment and economic burden of mucormycosis in China: case report review and burden estimation","volume":"47","author":"Jian","year":"2022","journal-title":"J Clin Pharm Ther"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1516117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T05:39:27Z","timestamp":1747028367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1516117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":20,"alternative-id":["10.3389\/fped.2025.1516117"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1516117","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"article-number":"1516117"}}